BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18677799)

  • 1. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Davis HR; Murgolo NJ; Graziano MP
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677799
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 4. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D
    N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kaye T
    N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
    [No Abstract]   [Full Text] [Related]  

  • 6. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract]   [Full Text] [Related]  

  • 7. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 8. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe prevents cholesterol gallstone formation in mice.
    Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
    Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    Michałek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol lowering and ezetimibe.
    Drazen JM; Jarcho JA; Morrissey S; Curfman GD
    N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
    [No Abstract]   [Full Text] [Related]  

  • 14. Ezetimibe plus simvastatin cardiovascular outcomes study program.
    Padial LR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 17. Ezetimibe, an inhibitor of intestinal cholesterol absorption, decreases serum level of malondialdehyde-modified low-density lipoprotein in patients with hypercholesterolemia.
    Ueda S; Miyake I; Takata K; Shimizu N; Shirotani K; Ishida S; Yonemitsu K; Maeyama T; Saito F; Saito H; Yamagishi S
    Int J Cardiol; 2011 Feb; 146(3):420-1. PubMed ID: 21106263
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treats two sources of cholesterol.
    Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.